At the news
? BEARISHIMPACT 7/10 CLUSTER filed Apr 15, 2026 at 17:29 ET
Two top executives at Cytokinetics, including the CEO and Chief Commercial Officer, sold nearly $1 million in shares over a single day, with both transactions occurring at market prices. This coordinated open-market selling by C-suite leaders signals potential lack of confidence in near-term prospects despite no disclosed negative news.
- CEO Robert Blum sold 7,500 shares for $490,350 at $65.38 per share on April 15, 2026
- EVP Andrew Callos sold 7,449 shares for $491,782.98 at $66.02 per share on April 15, 2026
- Total insider selling in the cluster: $982,132.98 over a 7-day window
- Both transactions were open-market sales (code S), not tax-related or automatic disposals
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access